In vitro activity of delafloxacin against highly levofloxacin-resistant invasive isolates of Streptococcus pneumoniae
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 40 (3) , 131-133
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- New antibiotics for community-acquired pneumoniaCurrent Opinion in Infectious Diseases, 2019
- The burden of community-acquired bacterial pneumonia in the era of antibiotic resistanceExpert Review of Respiratory Medicine, 2018
- Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic PropertiesInfectious Diseases and Therapy, 2018
- Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogensInternational Journal of Antimicrobial Agents, 2016
- In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 2016
- Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyFuture Microbiology, 2015
- Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic TechniquesPLOS ONE, 2013
- Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolidesMicrobes and Infection, 2012
- Clonal Spread of Levofloxacin-Resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain, 2007 to 2009Antimicrobial Agents and Chemotherapy, 2011
- Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in EnglandJournal of Antimicrobial Chemotherapy, 2003